Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Frenkel, IL

Anton Frenkel, Modi'In IL

Patent application numberDescriptionPublished
20090275653POLYMORPHIC FORMS OF LADOSTIGIL TARTRATE - The invention provides for solid state chemistry of ladostigil tartrate, particularly polymorphic forms of ladostigil tartrate, and processes for the preparation thereof.11-05-2009

Patent applications by Anton Frenkel, Modi'In IL

Assaf Frenkel, Ramat Hasharon IL

Patent application numberDescriptionPublished
20090007263Method and Apparatus for Combining Traffic Analysis and Monitoring Center in Lawful Interception - A method and apparatus for integrating intercepted information with information obtained from an at least one data retention source, the method comprising receiving intercepted information from an interception source, receiving information from a data retention source, and analyzing the information received from the data retention source, in association with the intercepted information. The intercepted information can comprise meta data related to the intercepted communications, and/or the contents of the communication themselves. This enables a user such as a law enforcement agency to reveal possibly indirect connections between target entities s wherein the connections involve non-target entities. The method and apparatus combine interception and content analysis methodologies with traffic analysis techniques.01-01-2009

Avraham Frenkel, Kiriat Bialik IL

Patent application numberDescriptionPublished
20090167628Ballistic Protective Radome - A ballistic protective radome (07-02-2009

Boris Frenkel, Netanya IL

Patent application numberDescriptionPublished
20100071776FLUID CONTROL VALVE SYSTEM AND METHODS - A diaphragm-type control valve having a diaphragm and a valve body is provided preferably for use in the separation of and fluid control between a fluid source and a pressurized gas volume. The diaphragm element and a port in the body together form an intermediate chamber that eliminates the need for a check-valve downstream of the valve. In one preferred embodiment, an inner surface of the valve body defines a chamber having an inlet and an outlet in communication with the chamber, and an elongated seat member defining a groove in communication with the port. A diaphragm member having upper and lower surfaces is disposed within the chamber. The lower surface preferably includes a pair of spaced apart elongated members defining a channel therebetween. The diaphragm member engages the seat member placing the channel in communication with the groove to define an air seat in communication with the port.03-25-2010

Patent applications by Boris Frenkel, Netanya IL

Dan Frenkel, Rechovot IL

Patent application numberDescriptionPublished
20100144868Novel Neuroprotective Compounds and Uses Thereof - Disclosed are novel hybrid compounds having a fullerene core residue, one or more bioavailability enhancing moieties and one or more glutamate receptor ligand residues, whereby the bioavailability enhancing moiety allow the compound to reach an effective concentration in physiological media and pass the blood-brain barrier, as defined in the specification. Also disclosed are pharmaceutical compositions containing these hybrid compounds and uses thereof as antioxidants and/or neuroprotective agents for the treatment of medical conditions associated with oxidative stress and/or neural damage, such as, for example, neurological diseases, disorders and trauma, and hence in the treatment of CNS-associated diseases, disorders and trauma, as well as to uses thereof as antiviral, antibacterial, antiglycemic, antiarrhythmic, antidepressant and antitumor agents.06-10-2010
20120028894PEPTIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USES THEREOF - Use of an isolated peptide comprising an amino acid sequence being no more than 25 amino acids in length, the amino acid sequence comprising at least one aspartate or a homolog thereof, the peptide having an Insulin-Degrading Enzyme (IDE) inhibitory activity, for the manufacture of a medicament identified for treating a disease selected from the group consisting of diabetes, obesity, hyperglycemia, retinal damage, renal failure, nerve damage, microvascular damage and varicella-zoster virus (VZV) infection is disclosed.02-02-2012

Dan Frenkel, Rehovot IL

Patent application numberDescriptionPublished
20080241169IMMUNIZATION AGAINST AMYLOID PLAQUES USING DISPLAY TECHNOLOGY - A strategy for immunizing against amyloid plaques using display technology. The strategy includes methods, agents, and pharmaceutical compositions for vaccination against plaque forming diseases (e.g., Alzheimer's disease) that rely upon presentation of an antigen or epitope on a display vehicle. The strategy further includes methods, agents, and pharmaceutical compositions for vaccination against plaque forming diseases (e.g., Alzheimer's disease) that rely upon presentation of an antibody, or an active portion thereof, on a display vehicle. Whether antigens or antibodies are employed, desegregation of plaques results from the immunization.10-02-2008

Doron Frenkel, Kfar-Sava IL

Patent application numberDescriptionPublished
20090210476SYSTEM AND METHOD FOR PROVIDING TANGIBLE FEEDBACK ACCORDING TO A CONTEXT AND PERSONALITY STATE - A system and method for maintaining a personality and an associated state and further causing an apparatus to perform tangible actions according to a personality, a state and a context. Embodiments of the invention may compute a state of a personality and a context according to detected events and input obtained. A state may further be computed according to a maintained context. An apparatus may be commanded to perform actions reflecting a computed state and context. Other embodiments are described and claimed.08-20-2009

Gustavo Frenkel, Beer Sheva IL

Patent application numberDescriptionPublished
20090137846Processes for the synthesis of O-Desmethylvenlafaxine - The present invention describes processes for the preparation of O-desmethylvenlafaxine and tridesmethylvenlafaxine, which may be used as an intermediate in preparing O-desmethylvenlafaxine.05-28-2009
20110237680CRYSTAL FORMS OF O-DESMETHYLVENLAFAXINE FUMARATE - Provided are crystalline forms of O-desmethylvenlafaxine fumarate, methods for their preparation, and pharmaceutical composition thereof.09-29-2011

Patent applications by Gustavo Frenkel, Beer Sheva IL

Hella Frenkel, Kfar-Saba IL

Patent application numberDescriptionPublished
20110284469Device and Method for Purifying a Liquid - A device for purifying a liquid in particular water is provided with an ozonating unit for treatment of said liquid with ozone and with a storage reservoir hydraulically connected to the ozonation unit. The device is provided with recirculation means for recirculating said treated liquid from said storage reservoir through a recirculation line. The recirculation line is provided with at least one filtration unit.11-24-2011

Herzel Frenkel, Ashdod IL

Patent application numberDescriptionPublished
20110092340EXERCISING MACHINE - The subject matter discloses an exercising device enabled to switch between elliptical course and circular course of footrests used by a user, comprising two main wheels, each connected to a different footrest; two connecting rods, the distal end of each connecting rod is connected to each main wheel and the proximal end of each connecting rod is connected to the body of the exercising device, said connecting rods are enabled to move the two main wheels on a horizontal axis.04-21-2011
20110177919A BICYCLE DEVICE HAVING MULTIPLE POSITION SEATS - The subject matter discloses a bicycle device capable of functioning as an upright bicycle and a recumbent bicycle using one seat. The bicycle device according may comprise a seat, a body, a wheel operated by the user of the exercising device and a directing rod connecting the body and the seat. Such that movement of the directing rod allows positioning the seat in front position used for upright bicycle and rear position used for recumbent bicycle.07-21-2011

Ilan Frenkel, Tel-Aviv IL

Patent application numberDescriptionPublished
20090132812METHOD AND APPARATUS FOR VERIFYING REVOCATION STATUS OF A DIGITAL CERTIFICATE - Verifying revocation status of a digital certificate is provided in part by a receiver verifying a security certificate for a sender. In an embodiment, an approach comprises receiving a first security certificate associated with the sender and storing the security certificate in a location accessible to the receiver; updating the first security certificate in the location accessible to the receiver if the first security certificate is changed or revoked; receiving a second security certificate from the sender when identity of the sender needs to be verified; comparing the second security certificate to the first security certificate; and confirming the sender's identity only if the second security certificate matches the first security certificate for the sender.05-21-2009

Patent applications by Ilan Frenkel, Tel-Aviv IL

Itai Frenkel, Tel Aviv IL

Patent application numberDescriptionPublished
20110214020ROOT CAUSE PROBLEM IDENTIFICATION THROUGH EVENT CORRELATION - Correlating activity events to identify a root cause of a process failure. Activity event data is received from a process executing on a computing device. The activity event data corresponds to a plurality of activity events. Each of the activity events has a correlation identifier, a resolution status, and an occurrence time value associated therewith. Each of the activity events are assigned to one of a plurality of event groups based on the correlation identifier of the activity event. Thereafter, at least one of the event groups is determined to have an activity event with a resolution status indicating failure of the process. One of the activity events within the determined event group is selected as a root cause activity event based on the occurrence time values. In some embodiments, the root cause activity event is identified to a user of the computing device.09-01-2011

Moshe Frenkel, Jerusalem IL

Patent application numberDescriptionPublished
20110081508PRETREATMENT LIQUID FOR WATER-BASED INK PRINTING APPLICATIONS - A pretreatment liquid for applying to the upper surface of a recording media, prior to printing of printing applications using water-based ink, is provided. The liquid comprises a polyvalent metallic salt and at least one of a polymer swelling and a coalescence reagent.04-07-2011
20120045583PROCESS FOR PRODUCING A PHOTOMASK ON A PHOTOPOLYMERIC SURFACE - A process is provided for printing a high resolution pattern on a photopolymeric surface.02-23-2012

Patent applications by Moshe Frenkel, Jerusalem IL

Omer Frenkel, Tel Aviv IL

Patent application numberDescriptionPublished
20100293146STATELESS VIRTUAL MACHINE - Some embodiments of using snapshotting and virtualization to perform tasks in a known and reproducible environment have been presented. A computing device generates a temporary snapshot of a state of a virtual machine. A session of the virtual machine is started on the computing device using the temporary snapshot. The temporary snapshot is automatically destroyed when the session is terminated, wherein any changes made to the state during the session are removed by destroying the temporary snapshot.11-18-2010
20100332657SELECTING A HOST FROM A HOST CLUSTER FOR LIVE MIGRATION OF A VIRTUAL MACHINE - A host controller migrates live virtual machines from one host to another host to balance the load in the host cluster. In one embodiment, the host controller identifies an overloaded host from the host cluster. The host controller selects a virtual machine from the existing virtual machines that run on the overloaded host based on a percentage value associated with the virtual machine. The percentage value represents CPU usage incurred by the virtual machine on the host. In one embodiment, the selected virtual machine is one that incurs the least amount of load on the host. The host controller then selects a target host from the host cluster as a destination for migrating the selected virtual machine.12-30-2010
20110035620Virtual Machine Infrastructure With Storage Domain Monitoring - A computing device monitors multiple hosts. A first host that does not have access to a data store is identified. A determination is made as to whether other hosts have access to the data store. When the other hosts do have access to the data store, it is determined that the first host is malfunctioning. A host error notification may then be sent to an administrator.02-10-2011
20110055372Auto Suspense Of Virtual Machine On Client Disconnection - A host controller or a host detects that a client has disconnected from a virtual machine running on the host. The host controller or host initiates a timer upon detecting that the client has disconnected. When the timer times out, the host controller or host saves the state of the virtual machine. The host controller or host causes the virtual machine to be shut down upon saving the state.03-03-2011
20110252271Monitoring of Highly Available Virtual Machines - A host controller is coupled to host computers that host virtual machines. At least one of the virtual machines is a highly available virtual machine. The host controller detects a change in system resources and identifies a highly available virtual machine that failed before the change occurs. The host controller re-runs the highly available virtual machine upon detection of the change of the system resources.10-13-2011

Orit Frenkel, Mda Tel Hashomer IL

Patent application numberDescriptionPublished
20120058156ACTIVATED LEUKOCYTE COMPOSITION AND USES FOR WOUND HEALING - Disclosed are therapeutic, blood-derived activated leukocyte compositions, methods of making them, and methods of using the compositions to repair or promote the prevention and healing of wounds.03-08-2012

Ran Frenkel, Yehud-Monosson IL

Patent application numberDescriptionPublished
20110121019Device for Drug Distribution and Method of Using Thereof - A medicament dispensing device comprises (a) at least one container adapted for accommodating and dispensing at least one elongate packagible elongate blister pack carrying a plurality of blisters containing the medicament; (b) transporting means adapted for transporting the blister pack toward opening of the container; (c) dispensing means adapted for releasing a fragment of the blister pack bearing a predetermined number of the blisters from the container through the opening to a patient; and (d) controlling means adapted for identifying the patient before dispensing the blister to the patient, activating the dispensing means, recording actions of dispensing. The substrate is foldable and configured to be folded within the container. The dispensing means is adapted to cut off the blister bearing fragment. The dispensing means adapted to cut off the blister bearing fragment such that the blisters remain intact.05-26-2011